Bap1 Mutation | List of Frontiers open access articles

Original Research

Published on 28 Feb 2020

Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings

in Cancer Imaging and Image-directed Interventions

Zhan Feng
Lixia Zhang
Zhong Qi
Qijun Shen
Zhengyu Hu
Feng Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.00279

9,316 views
43 citations

Original Research

Published on 24 Aug 2021

Germline BAP1 Mutation in a Family With Multi-Generational Meningioma With Rhabdoid Features: A Case Series and Literature Review

in Neuro-Oncology and Neurosurgical Oncology

Rahul N. Prasad
Ulysses G. Gardner
Alexander Yaney
Daniel M. Prevedello
Daniel C. Koboldt
Diana L. Thomas
Elaine R. Mardis
Joshua D. Palmer

Frontiers in Oncology

doi 10.3389/fonc.2021.721712

6,531 views
18 citations

Case Report

Published on 14 Mar 2022

Case Report and Review of Literature: Familial Malignant Pleural Mesothelioma in a 39 Years Old Patient With an Inconclusive 18F-FDG PET/CT Result

in Thoracic Surgery

Mayar Idkedek
Kareem S. Tahayneh
Firas Abu-Akar
Izzeddin A. Bakri

Frontiers in Surgery

doi 10.3389/fsurg.2022.819596

3,864 views
1 citation

Original Research

Published on 18 Oct 2021

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma

in Epigenomics and Epigenetics

Ze Gao
Junxiu Chen
Yiran Tao
Qiong Wang
Shirong Peng
Shunli Yu
Jianwen Zeng
Kaiwen Li
Zhongqiu Xie
Hai Huang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.747985

4,477 views
3 citations

Case Report

Published on 27 Nov 2020

Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma

in Molecular and Cellular Oncology

Francesco Sabbatino
Luigi Liguori
Umberto Malapelle
Francesca Schiavi
Vincenzo Tortora
Valeria Conti
Amelia Filippelli
Giampaolo Tortora
Cristina R. Ferrone
Stefano Pepe

Frontiers in Oncology

doi 10.3389/fonc.2020.567289

9,773 views
14 citations

Case Report

Published on 06 Jul 2022

Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review

in Genitourinary Oncology

Bi-Jun Lian
Ke Zhang
Xu-Dong Fang
Feng Li
Zhao Dai
Wei-Ying Chen
Xiao-Ping Qi

Frontiers in Oncology

doi 10.3389/fonc.2022.927250

4,456 views
10 citations

Original Research

Published on 27 Sep 2022

Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination

in Cancer Immunity and Immunotherapy

Kaidi Yang
Tongxin Yang
Tao Yang
Ye Yuan
Fang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.995651

4,448 views
8 citations

Articles

Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings

Germline BAP1 Mutation in a Family With Multi-Generational Meningioma With Rhabdoid Features: A Case Series and Literature Review

Case Report and Review of Literature: Familial Malignant Pleural Mesothelioma in a 39 Years Old Patient With an Inconclusive 18F-FDG PET/CT Result

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma

Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma

Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review

Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination